rs1553873247

Variant names:

• chr4-1938448-TAGAG-T
• rs1553873247
• NM_001042424.3:c.1676_1679delGAGA

Your query was ambiguous. Multiple possible variants found:

• chr4-1938448-TAGAG-T
• chr4-1938448-TAGAG-TAG

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1 PM2 PP3_Moderate PP5_Very_Strong

The NM_001042424.3(NSD2):​c.1676_1679delGAGA​(p.Arg559fs) variant causes a frameshift, splice region change. The variant allele was found at a frequency of 0.00000224 in 894,778 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

• Frequency:
  • Genomes: not found (cov: 18)
  • Exomes 𝑓: 0.0000022 (0 hom.)
• Consequence: NSD2 NM_001042424.3 frameshift, splice_region
• Clinical Significance: Pathogenic criteria provided, multiple submitters, no conflicts P:11
• Conservation: PhyloP100: 5.97

Genes affected

NSD2 (HGNC:12766): (nuclear receptor binding SET domain protein 2) This gene encodes a protein that contains four domains present in other developmental proteins: a PWWP domain, an HMG box, a SET domain, and a PHD-type zinc finger. It is expressed ubiquitously in early development. Wolf-Hirschhorn syndrome (WHS) is a malformation syndrome associated with a hemizygous deletion of the distal short arm of chromosome 4. This gene maps to the 165 kb WHS critical region and has also been involved in the chromosomal translocation t(4;14)(p16.3;q32.3) in multiple myelomas. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. Some transcript variants are nonsense-mediated mRNA (NMD) decay candidates, hence not represented as reference sequences. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Pathogenic. Variant got 20 ACMG points.

• PVS1: Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
• PM2: Very rare variant in population databases, with high coverage
• PP3: Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
• PP5: Variant 4-1938448-TAGAG-T is Pathogenic according to our data. Variant chr4-1938448-TAGAG-T is described in ClinVar as [Pathogenic]. Clinvar id is 547999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-1938448-TAGAG-T is described in Lovd as [Pathogenic]. Variant chr4-1938448-TAGAG-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
NSD2	NM_001042424.3	c.1676_1679delGAGA	p.Arg559fs	frameshift_variant, splice_region_variant	Exon 8 of 22	ENST00000508803.6	NP_001035889.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
NSD2	ENST00000508803.6	c.1676_1679delGAGA	p.Arg559fs	frameshift_variant, splice_region_variant	Exon 8 of 22	1	NM_001042424.3	ENSP00000423972.1

Frequencies

GnomAD3 genomes Cov.: 18

GnomAD4 exome AF: 0.00000224 AC: 2 AN: 894778 Hom.: 0 AF XY: 0.00 AC XY: 0 AN XY: 463916

Gnomad4 AFR exome AF: 0.00

Gnomad4 AMR exome AF: 0.00

Gnomad4 ASJ exome AF: 0.00

Gnomad4 EAS exome AF: 0.00

Gnomad4 SAS exome AF: 0.00

Gnomad4 FIN exome AF: 0.0000213

Gnomad4 NFE exome AF: 0.00000158

Gnomad4 OTH exome AF: 0.00

GnomAD4 genome Cov.: 18

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:11

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Rauch-Steindl syndrome Pathogenic:4

Jan 11, 2022

OMIM

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: literature only

- -

Mar 17, 2022

Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

PVS2, PS2, PM2 -

-

Juno Genomics, Hangzhou Juno Genomics, Inc

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

PM2_Supporting+PVS1+PS4_Supporting+PS2_Moderate -

Oct 26, 2022

New York Genome Center

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The de novo c.1676_1679del variant identified in the NSD2 gene has previously been reported as de novo variant in individuals with NSD2-related disorder with features of developmental delay, cardiac defects, and multiple congenital malformations [PMID: 30345613, 26785492, 33144682] and it has been deposited in ClinVar [ClinVar ID: 547999] as Pathogenic. The c.1676_1679del variant is observed in 1 allele (~0.00062% minor allele frequency with 0 homozygotes) in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8, All of Us), suggesting it is not a common benign variant in the populations represented in those databases. The c.1676_1679del variant in NSD2 is located in exon 8 of this 22-exon gene, predicted to incorporate a premature termination codon approximately 38 amino acids downstream (p.(Arg559ThrfsTer38)), and is expected to result in loss-of-function via nonsense mediated decay. Multiple loss-of-function variants that are downstream to the c.1676_1679del variant have been reported in the literature [PMID: 31382906, 33941880] and ClinVar [ClinVar ID: 1333177] in individuals with Rauch-Steindl syndrome. Based on available evidence this de novo c.1676_1679del (p.(Arg559ThrfsTer38)), variant identified in NSD2 is classified here as Pathogenic. -

not provided Pathogenic:3

Dec 11, 2024

GeneDx

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33144682, 30345613, 26785492, 38251460, 33084842, 32368696, 31941532) -

Sep 07, 2021

Molecular Genetics laboratory, Necker Hospital

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Feb 01, 2020

CeGaT Center for Human Genetics Tuebingen

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

NSD2-related disorder Pathogenic:1

Aug 14, 2024

PreventionGenetics, part of Exact Sciences

Significance: Likely pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

The NSD2 c.1676_1679delGAGA variant is predicted to result in a frameshift and premature protein termination (p.Arg559Thrfs*38). This variant was reported de novo in at least one individual with congenital heart disease (as 4:1940175 TAGAG>T in WHSC1; Dataset S2, Homsy et al. 2015. PubMed ID: 26785492; Dataset S2, Sevim Bayrak et al. 2020. PubMed ID: 31941532; Edwards et al. 2020. PubMed ID: 32368696; eTable 4, Morton et al. 2021. PubMed ID: 33084842) and also was reported de novo in at least one individual with developmental delays, mild facial dysmorphisms, short stature, failure to thrive, and microcephaly (as: c.1676_1679del (p.Arg559Tfs*38) in WHSC1; Boczek et al. 2018. PubMed ID: 30345613; Klee et al. 2020. PubMed ID: 33144682). This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in NSD2 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -

Global developmental delay Pathogenic:1

Oct 25, 2021

3billion

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant has been reported to be associated with [GeneName] related disorder (ClinVar ID: VCV000547999.8). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -

Neurodevelopmental delay Pathogenic:1

-

Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

4p partial monosomy syndrome Pathogenic:1

Sep 29, 2017

Mayo Clinic Laboratories, Mayo Clinic

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.90		Details are displayed if max score is > 0.2
DS_AG_spliceai		0.85		Position offset: 7
DS_AL_spliceai		0.90		Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1553873247; hg19: chr4-1940175;